ALT.NASDAQAltimmune, INC

Form 4: Altimmune CFO Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


Gregory L Weaver, Chief Financial Officer of Altimmune, Inc., reported multiple transactions in common stock on October 1, 2026.

Summary

  • Option exercise/conversion: acquired 14,475 Common Stock, par value $0.0001 on October 1, 2026; holds 54,306 after (Direct).
  • Tax/exercise-price withholding: disposed of 4,379 Common Stock, par value $0.0001 at $2.76 ($12,086) on October 1, 2026; holds 49,927 after (Direct).
  • Option exercise/conversion: disposed of 14,475 Restricted Stock Units on October 1, 2026; holds 43,425 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Gregory L Weaver — Officer (Chief Financial Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-10-01Option exercise/conversionCommon Stock, par value $0.000114,475——54,306
2026-10-01Tax/exercise-price withholdingCommon Stock, par value $0.00014,379$3$12.1K49,927
2026-10-01Option exercise/conversionRestricted Stock Units14,475——43,425

Key Dates

DateDescription
2026-10-01Option exercise/conversion (14,475 shares)
2026-10-01Tax/exercise-price withholding (4,379 shares)
2026-10-01Option exercise/conversion (14,475 shares)

Keywords

insider transaction, Form 4, ALT, Altimmune, Inc., neutral, Gregory L Weaver

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.